Glaukos
GKOS · NYSE
Bulios Fair Price
$111.27
32.1% downside
Trenutna cena
$163.82
Po podatkih Bulios Fair Price je delnica GKOS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Glaukos Corporation is an American biotechnology company focused on the development and manufacture of innovative ophthalmic products. Founded in 1998, its headquarters are located in San Clemente, California. Glaukos specializes in the treatment of glaucoma and other eye diseases using new technologies, including implants and micro-surgical solutions. The company focuses on improving patients' quality of life through groundbreaking products and services that bring innovation to the field of ophthalmology.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Devices
CEO
Thomas William Burns
Employees
1,094
Headquarters
Aliso Viejo
Prihajajoči dogodki
Earnings
Upcoming earnings report